• SPX
  • $5,859.85
  • 0.77 %
  • $44.82
  • DJI
  • $43,065.22
  • 0.47 %
  • $201.36
  • N225
  • $40,088.61
  • 1.22 %
  • $482.88
  • FTSE
  • $8,292.66
  • 0.47 %
  • $39.01
  • IXIC
  • $18,502.69
  • 0.87 %
  • $159.75
CONMED Corporation (CNMD) Stock Price, News & Analysis

CONMED Corporation (CNMD) Stock Price, News & Analysis

Currency in USD Disclaimer

$64.59

$0.57

(0.89%)

Day's range
$62.87
Day's range
$65.13
50-day range
$61.45
Day's range
$78.19
  • Country: US
  • ISIN: US2074101013
52 wk range
$61.05
Day's range
$117.27


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2.10
  • Piotroski Score 7.00
  • Grade Buy
  • Symbol (CNMD)
  • Company CONMED Corporation
  • Price $64.59
  • Changes Percentage (0.89%)
  • Change $0.57
  • Day Low $62.87
  • Day High $65.13
  • Year High $117.27

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

  • Last Earnings 08/09/2024
  • Ex-Dividend for 5/16 Dividend 09/16/2024
  • Dividend Payable 10/04/2024
  • Today N/A
  • Next Earnings (Estimated) 10/30/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $96.00
  • High Stock Price Target $97.00
  • Low Stock Price Target $95.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $2.61
  • Trailing P/E Ratio 29.28
  • Forward P/E Ratio 29.28
  • P/E Growth 29.28
  • Net Income $64.46 M

Income Statement

Quarterly

Annual

Latest News of CNMD

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.